Revolution Medicines Total Risk Alpha
| RVMD Stock | | | USD 93.21 -1.08 -1.15% |
This dataset for Revolution Medicines reflects inputs used in the Total Risk Alpha calculation. This dataset is part of a broader indicator framework including
Equity Screeners. Revolution Medicines has a market cap of 18.69 B, current ratio of 7.6. Portfolio-level context is available through
Your Equity Center. Tracking Revolution Medicines in a portfolio provides context for performance attribution. All metrics are derived from available inputs and shown for reference. Broader economic conditions can influence Revolution Medicines's company valuation — related indicators include
signals in inflation.
Additional detail on trading Revolution Stock is available in our
How to Trade Revolution Stock guide.
Revolution Medicines has current Total Risk Alpha of 0.7735. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.7735 | |
| ER[a] | = | Expected return on investing in Revolution Medicines |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Revolution Medicines |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Revolution Medicines holds the
#2 position for total risk alpha relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers with a Maximum Drawdown-to-Total Risk Alpha ratio near
58.83 . The Maximum Drawdown to Total Risk Alpha ratio for Revolution Medicines comes in at
58.83 The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Revolution Medicines to Peers
Other Technical Indicators